13D/13G Filings - LIFECORE BIOMEDICAL INC. (LFCR)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-10
11:14 am
Purchase
2020-12-31 13G Lifecore Biomedical, Inc.
LFCR
The Vanguard Group 1,671,841
5.720%
52,739increase
(+3.26%)
Filing
History
2021-01-29
5:23 pm
Purchase
2020-12-31 13G Lifecore Biomedical, Inc.
LFCR
BlackRock Inc.
BLK
2,091,030
7.200%
79,319increase
(+3.94%)
Filing
History
2020-08-24
09:15 am
Purchase
2020-08-21 13D Lifecore Biomedical, Inc.
LFCR
Legion Partners Asset Management LLC 2,904,340
9.930%
38,000increase
(+1.33%)
Filing
History
2020-07-10
06:19 am
Sale
2020-06-30 13G Lifecore Biomedical, Inc.
LFCR
NWQ INVESTMENT MANAGEMENT COMPANY LLC 893,126
3.061%
-1,215,468decrease
(-57.64%)
Filing
History
2020-06-22
4:43 pm
Purchase
2020-06-18 13D Lifecore Biomedical, Inc.
LFCR
Legion Partners Asset Management LLC 2,866,340
9.820%
484,847increase
(+20.36%)
Filing
History
Goto Prev, 0, 1, 2